149 related articles for article (PubMed ID: 37898793)
21. Melanoma of the glans penis.
Betti R; Menni S; Crosti C
Eur J Dermatol; 2005; 15(2):113-5. PubMed ID: 15757826
[TBL] [Abstract][Full Text] [Related]
22. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma.
Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH
Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628
[TBL] [Abstract][Full Text] [Related]
23. Preferentially Expressed Antigen in Melanoma (PRAME) and Human Malignant Melanoma: A Retrospective Study.
Cazzato G; Mangialardi K; Falcicchio G; Colagrande A; Ingravallo G; Arezzo F; Giliberti G; Trilli I; Loizzi V; Lettini T; Scarcella S; Annese T; Parente P; Lupo C; Casatta N; Maiorano E; Cormio G; Resta L; Ribatti D
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328098
[TBL] [Abstract][Full Text] [Related]
24. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
Bahmad HF; Oh KS; Alexis J
J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
[TBL] [Abstract][Full Text] [Related]
25. [Malignant melanoma of the penis associated with von Recklinghausen's neurofibromatosis: report of a case].
Miyauchi T; Maruoka M; Nagayama T
Hinyokika Kiyo; 1988 Apr; 34(4):710-3. PubMed ID: 3135709
[TBL] [Abstract][Full Text] [Related]
26. Up-Regulation of PARP1 Expression Significantly Correlated with Poor Survival in Mucosal Melanomas.
Donizy P; Wu CL; Mull J; Fujimoto M; Chłopik A; Peng Y; Shalin SC; Selim MA; Puig S; Fernandez-Figueras MT; Shea CR; Biernat W; Ryś J; Marszalek A; Hoang MP
Cells; 2020 May; 9(5):. PubMed ID: 32380691
[TBL] [Abstract][Full Text] [Related]
27. [A case of malignant melanoma of the penis].
Watanabe T; Kura N; Yamada T; Negishi T
Hinyokika Kiyo; 1991 Jun; 37(6):637-9. PubMed ID: 1892014
[TBL] [Abstract][Full Text] [Related]
28. [Malignant melanoma of the penile fossa navicularis].
Lüchtrath H; Schmich HR
Urologe A; 1984 Sep; 23(5):285-7. PubMed ID: 6542271
[TBL] [Abstract][Full Text] [Related]
29. Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines.
Cakir OO; Pozzi E; Castiglione F; Freeman A; Haider A; Rees R; Alnajjar HM; Bunker C; Muneer A
Melanoma Res; 2022 Feb; 32(1):27-34. PubMed ID: 34840322
[TBL] [Abstract][Full Text] [Related]
30. Nodular primary cutaneous melanoma is associated with PD-L1 expression.
Giavina-Bianchi M; Giavina-Bianchi P; Sotto MN; Rodig S; Mihm M; Festa Neto C; Duncan LM; Kalil J
Eur J Dermatol; 2020 Aug; 30(4):352-357. PubMed ID: 32969795
[TBL] [Abstract][Full Text] [Related]
31. Primary malignant melanoma of the penis: a case report.
Dogu GG; Yaren A; Tuncay L; Senturk N; Zumrutbas AE; Taskoylu BY; Bir F
Med Oncol; 2012 Jun; 29(2):1300-3. PubMed ID: 21327740
[TBL] [Abstract][Full Text] [Related]
32. [Penile malignant melanoma of the glans penis].
Wallentin RS; Sjøgren P
Ugeskr Laeger; 2014 Jan; 176(4A):V05100177. PubMed ID: 25347254
[TBL] [Abstract][Full Text] [Related]
33. Melanoma in situ of penis: a very rare entity: A case report and review of the literature.
Baraziol R; Schiavon M; Fraccalanza E; De Giorgi G
Medicine (Baltimore); 2017 Sep; 96(36):e7652. PubMed ID: 28885326
[TBL] [Abstract][Full Text] [Related]
34. Primary malignant melanoma of the penis. Two cases and a review of the literature.
Khezri AA; Dounis A; Roberts JB
Br J Urol; 1979 Apr; 51(2):147-50. PubMed ID: 465973
[TBL] [Abstract][Full Text] [Related]
35. The programmed cell death protein-1/programmed cell death ligand 1 expression, CD3+ T cell infiltration, NY-ESO-1 expression, and microsatellite instability phenotype in primary cutaneous melanoma and mucosal melanoma and their clinical significance and prognostic value: a study of 89 consecutive cases.
Ren Y; Lv Q; Yue W; Liu B; Zou Z
Melanoma Res; 2020 Feb; 30(1):85-101. PubMed ID: 31095042
[TBL] [Abstract][Full Text] [Related]
36. Early 'invasive' malignant melanoma of the glans penis and the male urethra. Report of a case and review of the literature.
Primus G; Soyer HP; Smolle J; Mertl G; Pummer K; Kerl H
Eur Urol; 1990; 18(2):156-9. PubMed ID: 2226587
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab.
Brüggemann C; Kirchberger MC; Goldinger SM; Weide B; Konrad A; Erdmann M; Schadendorf D; Croner RS; Krähenbühl L; Kähler KC; Hafner C; Leisgang W; Kiesewetter F; Dummer R; Schuler G; Stürzl M; Heinzerling L
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1977-1984. PubMed ID: 28616701
[TBL] [Abstract][Full Text] [Related]
38. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches.
Udager AM; Liu TY; Skala SL; Magers MJ; McDaniel AS; Spratt DE; Feng FY; Siddiqui J; Cao X; Fields KL; Morgan TM; Palapattu GS; Weizer AZ; Chinnaiyan AM; Alva A; Montgomery JS; Tomlins SA; Jiang H; Mehra R
Ann Oncol; 2016 Sep; 27(9):1706-12. PubMed ID: 27217541
[TBL] [Abstract][Full Text] [Related]
39. Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status.
Po JW; Ma Y; Balakrishna B; Brungs D; Azimi F; de Souza P; Becker TM
PLoS One; 2019; 14(2):e0211866. PubMed ID: 30735560
[TBL] [Abstract][Full Text] [Related]
40. Melanoma in situ of the penis.
Demitsu T; Nagato H; Nishimaki K; Okada O; Kubota T; Yoneda K; Manabe M
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 2):386-8. PubMed ID: 10640941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
